The consumer reported a false negative result with the binaxnow covid-19 antigen self test performed on (b)(6) 2024 on a nasal swab.Confirmation pcr testing (platform - unknown) was performed on the 29jan2024 which generated a positive result.The consumer stated the patient was asymptomatic.The consumer confirmed there was no death or serious injury due to the test results.No additional patient information, including treatment and outcome, was provided.
|
D4 udi: (b)(4).Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 225360 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160/ lot 225360, test base part number 195-430h/ lot 221803.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 225360 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue; however, it could possibly be related to issues including the self-test user performance, interpretation of the result, or the specific patient sample.H3 other text : single-use, device discarded.
|